GILDER GAGNON HOWE & CO LLC

Position in KRYS — Krystal Biotech, Inc.

CIK 902464 New York, NY

Position in KRYS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$14,976,814

+$4,610,950 QoQ

Shares Held

40,296

+0.4% QoQ

Ownership

0.136%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#65

of 419 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GILDER GAGNON HOWE & CO LLC holds $353,222,516 across 21 Biotechnology names. KRYS ranks #9 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	269,051	$80,992,422
2	NKTR	Nektar Therapeutics	600,873	$41,946,944
3	BBIO	BridgeBio Pharma, Inc.	548,926	$40,884,008
4	ARQT	Arcutis Biotherapeutics, Inc.	1,313,211	$34,432,392
5	CYTK	Cytokinetics Inc	400,245	$34,096,871
6	KYMR	Kymera Therapeutics, Inc.	229,053	$26,265,507
7	QURE	uniQure N.V.	530,979	$24,456,892
8	MDGL	Madrigal Pharmaceuticals, Inc.	28,573	$15,342,272

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,976,814	40,296	+0.4%	Shares	Sole	2026-08-14
2026-03-31	$10,365,864	40,128	+433.1%	Shares	Sole	2026-05-15
2023-12-31	$933,799	7,527	-0.0%	Shares	Sole	2024-02-14
2023-09-30	$873,248	7,528	+0.3%	Shares	Sole	2023-11-14
2023-06-30	$880,852	7,503	+33.3%	Shares	Defined	2023-08-14
2023-03-31	$450,497	5,627	-16.9%	Shares	Defined	2023-05-15
2021-03-31	$521,483	6,769	-0.2%	Shares	Defined	2021-05-17
2020-12-31	$406,980	6,783	-5.1%	Shares	Defined	2021-02-16
2020-09-30	$307,635	7,146	-3.7%	Shares	Defined	2020-11-16
2020-06-30	$307,377	7,421	+19956.8%	Shares	Defined	2020-08-14
2020-03-31	$1,599	37	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.